The healthcare ecosystem insights report shelters a comprehensive study of the healthcare sector in the U.K., the U.S., Germany, China, Singapore, France, and Japan.
The development of the industry in the seven countries can be credited to the growing count of cases of chronic illnesses, growing acceptance of healthcare insurance, growing demand for in-vitro diagnostic (IVD) tests, thriving elderly populace, rising gross domestic product (GDP) and healthcare investments, government initiatives, advancing healthcare infrastructure, and fast digitization in the medicinal ecosystem.
Based on type, the cardiovascular and circulatory diseases category, is projected to generate the highest revenue of more than 42.6% in Germany, experiencing a CAGR of 3.3% in the coming few years. This is mainly because cardiovascular disorders (CVDs) are the most widespread chronic diseases in the nation. The cancer category is estimated to be the second-largest category in the German industry, with a 26.5% share, in the coming years.
On the basis of channel, in recent years, the state/local category had the third position in the Japanese industry, accounting for more than 17.4% industry share. This was because fewer healthcare facilities are provided at the state/local level in the nation.
Industry Dynamics
The healthcare sector development in the seven nations is boosted by the rise in the elderly populace, growing demand for IVD tests, digitalization in the healthcare industry, and widescale acceptance of healthcare insurance. The Elderly has a direct link with chronic illnesses, like CVDs, neurological circumstances, and rheumatoid arthritis.
The growing life expectancy and lessening death rates are the main contributors to the growing elderly populace throughout the world. As per the World Bank, the populace of individuals aged 65 years or above grew from 34.2 million in 2017 to 40.1 million in 2021 in Japan and from 13.2 million in 2017 to 19 million in 2021 in France.
Additionally, an analysis by the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) of Japanese people old 75 years and more exposed that more than 65% of these people were living with at least three co-occurring illnesses, like coronary heart disease, hypertension, and peptic ulcers. Since elder people are extremely vulnerable to these ailments, the growing elderly populace in such nations will boost the requirement for medicine and other medical amenities in the coming years.
Furthermore, the rising demand for IVD tests will ease the healthcare sector development in the coming few years. The growing utilization of IVD tests can be credited to their fast and dependable outcomes, smooth information recording capability, to confirm the results, simple repeatability, numerous tests performing ability, and skill to sense an extensive variety of substances in the body.
For example, China is generating a high demand for such tests because of the growing occurrence of chronic diseases among the elderly populace, several of which can be identified and monitored via IVD products. Moreover, the growing acceptance of health insurance guidelines is having a positive effect on market development, as health insurance decreases the financial load on patients.